Attachment J.25 ASPIRE Required PEPFAR Indicators and COP20 ASPIRE Targets.pdf

PDF 45 KB Posted

Attached to
Attain & Sustain 95-95-95, Prevent New Infections and Reach All Populations for Epidemic Control (ASPIRE) Activity
Solicitation number
72067419R00015
Issued by

About this file

This document contains details on a forthcoming request for proposal from the United States Agency for International Development South Africa for the Attain & Sustain 95-95-95, Prevent New Infections and Reach All Populations for Epidemic Control activity in Eswatini. The goal of the activity is to reduce HIV incidence and AIDS-related mortality by achieving and sustaining 95-95-95 treatment targets and preventing new infections across all populations in the Hhohho and Shiselweni regions. The activity will provide technical assistance at the national and regional levels to support increasing access to and utilization of comprehensive HIV services, increasing uptake of biomedical prevention services and integrated sexual and reproductive health services, and improving Ministry of Health capacity for strategic oversight of HIV clinical services and select maternal and child health programs. USAID intends to award a five-year cost-plus-fixed-fee completion contract valued between $58-60 million through full and open competition. Interested parties should monitor the fedbizopps website for additional details on the forthcoming request for proposal.

View the file

Other files

File Type Posted
Attachment J.10 Initial Environmental Examination RHAP.pdf PDF
Attachment J.23 Current PEPFAR-Supported Facilities in Hhohho and Shiselweni.pdf PDF
Amendment No 4 Revised RFP 72067419R00015.pdf PDF
Responses to ASPIRE Questions.pdf PDF
Attachment J.3_Budget_Template Revised.xls XLS spreadsheet
SF 30 Amendment No 4 RFP 72067419R00015 (1).pdf PDF
Amendment No 3 Revised RFP 72067419R00015.docx DOCX document
SF 30 Amendment No 3 RFP 72067419R00015.pdf PDF
ASPIRE_RFP_Revised_for_Amendment_2_20190910.pdf PDF
ASPIRE_Amendment_02_SF-30_Cover_Page.pdf PDF
J.3_Budget_Template_revised.xls XLS spreadsheet
ASPIRE_Amendment_01_Questions_and_Answers.pdf PDF
J.11_USAID_Small_Business_Subcontracting_Plan_Template_revised.pdf PDF
J.23_PEPFAR_supported_sites_in_Hhohho_and_Shiselweni.pdf PDF
J.25_ASPIRE_Required_PEPFAR_Indicators_and_COP19_ASPIRE_Targets.pdf PDF
J.27_Fixed_Fee_Schedule_Template.xlsx XLSX spreadsheet
ASPIRE_RFP_for_Revised_for_Amendment_01_20190826.pdf PDF
J.26_Eswatini_LCP_Bands.pdf PDF
ASPIRE_Amendment_01_SF-30_Cover_Page.pdf PDF
J.20_Sexual_and_Reproductive_Health_(SRH)_2018_Annual_Program_Report.pdf PDF
J.3_Budget_Template.xls XLS spreadsheet
J.17_HIV_2018_Annual_Program_Report.pdf PDF
J.18_National_Tuberculosis_Strategic_Plan_(2015-2019).pdf PDF
J.14_MER_Indicator_Reference_Guide_(Version_2.3_FY19).pdf PDF
J.22_The_National_Multisectoral_HIV_and_AIDS_Strategic_Framework_(NSF)_2018-2023.pdf PDF
72067419R00015_USAID_ASPIRE.pdf PDF
J.16_Clinical_Implementation_Guide_for_PrEP_Provision_in_Eswatini,_2019.pdf PDF
J.15_Swaziland_Integrated_HIV_Management_Guidelines_2018.pdf PDF
J.19_National_Strategic_Plan_for_Ending_AIDS_and_Syphilis_in_Children_(2018-2022).pdf PDF
J.21_Annual_TB_Program_Report_2018.pdf PDF
Show all 30

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

ATTACHMENT J.25 ASPIRE Required PEPFAR Indicators and COP20

ASPIRE Targets

MER Indicator COP20 Target Indicator Description

HTS_TST 46,491

Number of individuals who received HIV

Testing Services (HTS) and received their test results

HTS_TST_POS 2,937

Number of individuals who received HIV

Testing Services (HTS), received their test results, and tested HIV positive.

HTS_INDEX 27,684

Number of individuals who were identified and tested using Index testing services and received their results

HTS_INDEX_POS 2,201

Number of individuals who were identified and tested using Index testing services and received their results and tested HIV positive

HTS_SELF 14,243

Number of individual HIV self-test kits distributed

TB_PREV 19,262

Proportion of ART patients who completed a standard course of TB preventive therapy within the semiannual reporting period

TB_STAT 953

Percentage of new and relapse TB cases with documented HIV status

TB_ART 573

Proportion of HIV-positive new and relapsed TB cases on ART during TB treatment

TX_NEW 2,891

Number of adults and children newly enrolled on antiretroviral therapy (ART)

TX_CURR 80,267

Number of adults and children currently receiving antiretroviral therapy (ART)

TX_PVLS 76,544

Percentage of ART patients with a suppressed viral load (VL) result (<1000 copies/ml) documented in the medical or laboratory records/laboratory information systems (LIS) within the past 12 months

PMTCT_STAT 15,317

Percentage of pregnant women with known HIV status at antenatal care

(includes those who already knew their

HIV status prior to ANC)

PMTCT_ART 3,853

Percentage of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission

(MTCT) during pregnancy

PMTCT_EID 3,727

Percentage of infants born to HIV-positive women who received a first virologic HIV test (sample collected) by 12 months of age

VMMC_CIRC 2,168

Number of males circumcised as part of the voluntary medical male circumcision

(VMMC) for HIV prevention program within the reporting period

CXCA_SCRN 18,930

Percentage of HIV-positive women on

ART screened for cervical cancer

PrEP_NEW 3,007

Number of individuals who have been newly enrolled on antiretroviral preexposure prophylaxis (PrEP) to prevent

HIV infection in the reporting period

PrEP_CURR 4,885

Number of individuals, inclusive of those newly enrolled, that received oral antiretroviral pre-exposure prophylaxis

(PrEP) to prevent HIV during the reporting period

GEND_GBV 1,891

Number of people receiving post-gender-based violence (GBV) clinical care based on the minimum package

File details come from the government source that posted it. Updated .